Company Sarmexin Srl with Fiscal Code 28072082
recorded a turnover of 2024 of
177.221,
with a net profit of
1.515
and having an average number of employees of
8.
The company operates in the field of Fabricarea de mobila n.c.a. having the NACE code 3109.
Sales - Ron
Sales, Profit, Employees, Total Income, Financial Results -
Sarmexin Srl
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Sales - EUR
96.076
153.192
188.650
147.762
127.542
81.194
113.651
120.695
185.752
177.221
Total Income - EUR
119.104
149.676
265.557
207.175
234.101
115.069
415.821
176.468
198.848
199.562
Total Expenses - EUR
116.461
147.273
246.668
203.974
227.424
153.593
187.295
171.260
195.388
192.730
Gross Profit/Loss - EUR
2.643
2.402
18.889
3.200
6.677
-38.525
228.525
5.209
3.460
6.832
Net Profit/Loss - EUR
1.147
344
16.265
1.436
4.064
-39.331
225.255
3.538
1.603
1.515
Employees
15
23
18
16
15
12
11
8
8
8
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity as found at the Ministry of Finance. The data provides the evolution of the company during this period regarding the increases and possibly decreases recorded.
In the last year of activity, the sales decreased by -4.1%, from 185.752 euro in the year 2023, to 177.221 euro in 2024.
The Net Profit decreased by -78 euro, from 1.603 euro in 2023, to 1.515 in the last year.
Check the financial reports for the company - Sarmexin Srl
Financial Rating - SARMEXIN SRL
See the company's note based on the submitted financial data, relative to the industry of which it is a part.
Financial Rating
Payment Limits - Sarmexin Srl
See the company's payment capacity for situations in which you conclude contracts with payment terms.
Check Payment Limits
Prob. of insolvency - Sarmexin Srl
It determines the risk of insolvency based on the submitted accounting balance.
Insolvency Probability
Financial Reports - Sarmexin Srl
Check all the financial reports of the company and know the risks in collaboration with it.
Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of
148.760 euro in 2024 which includes Inventories of
131.757 euro, Receivables of
16.359 euro and cash availability of
644 euro.
The company's Equity was valued at
8.810 euro, while total Liabilities amounted to
152.495 euro.
Equity increased by 1.753 euro, from 7.098 euro in 2023, to 8.810 in 2024.
Similar services useful for checking companies and business development.
SellNet
Get the contact details for any company and get in touch with it.
Sectoral Studies
Knows the market and develops its own development strategies according to sectorial data.
Databases
Export in excel files the data of the companies selected according to the desired criteria.
Import - Export
Find importers and exporters according to the type of activity and the countries in which they carry it out.
Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.
Comments - Sarmexin Srl